
Conference Coverage
Latest Content

Rising Pediatric Diabetes Trends in US Medicaid, CHIP Enrollees

Early Add-On Therapy Associated With Strong Clinical Response in MG

Contributor: Personalized Heart Risk and How AI-Powered Plaque Analysis Is Changing Prevention

Income Inequality Fuels Worsening Birth Outcomes

Medicare Advantage Reckoning Hits 2026 Enrollment: Mark Meiselbach, PhD

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

Investigators in China touted durable responses seen in a phase 2 study of the CAR T-cell therapy relma-cel, which has a similar mechanism of action as liso-cel. At present, there are no approved CAR T-cell therapies for relapsed/refractory mantle cell lymphoma in China.

Environmental factors were a barrier to participation in community activities among people with multiple sclerosis, even after adjusting for personal factors like disease severity.

A new review highlights the potential to develop ways to better anticipate and treat Richter transformation in patients with chronic lymphocytic leukemia.

Clinical measures and biomarkers during pregnancy, including hs-cTnI and sFlt-1, can help identify women at higher risk of developing cardiovascular disease later in life.

Genmab’s epcoritamab (Epkinly) streamlines bispecific antibody workflows for DLBCL and follicular lymphoma, cutting chair time, waste, and costs.

In a cohort of veterans with steatotic liver disease, patients with metabolic- and alcohol-associated liver disease had the lowest incidence of cirrhosis.

Patients with both a low estimated glomerular filtration rate and a high protein-to-creatinine ratio were at particularly high risk of cognitive impairment, a new study has found.

Transcriptomic analysis revealed that chronic hand eczema shares overlapping immune signatures with both atopic dermatitis and psoriasis.

Meta-analysis links obstructive sleep apnea to early kidney injury markers, especially in severe OSA and hypertension, highlighting need for renal monitoring.

Sociodemographic Disparities in Outcomes, Costs, and Care in Obstructive Hypertrophic Cardiomyopathy
Patients with oHCM experience significant variation in cardiovascular events, health care resource use, and costs across age, sex, race, and US region.



































